US 11,963,677 B2
Facial invasive tissue treatment method
Xiaoqin Ling, Temple City, CA (US)
Filed by Xiaoqin Ling, Temple City, CA (US)
Filed on Jul. 2, 2022, as Appl. No. 17/856,962.
Application 17/856,962 is a continuation of application No. 17/555,393, filed on Dec. 18, 2021, granted, now 11,413,038.
Prior Publication US 2023/0190265 A1, Jun. 22, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61B 17/06 (2006.01); A61B 90/00 (2016.01); A61B 17/00 (2006.01); A61B 17/04 (2006.01)
CPC A61B 17/06166 (2013.01) [A61B 17/06066 (2013.01); A61B 90/39 (2016.02); A61B 2017/00792 (2013.01); A61B 2017/0414 (2013.01); A61B 2017/0464 (2013.01); A61B 2017/06176 (2013.01); A61B 2090/395 (2016.02)] 20 Claims
OG exemplary drawing
 
1. A facial invasive tissue treatment method, comprising steps of:
(i) marking one or more front facelift suture path lines, one or more mid facelift suture path lines and one or more side facelift suture path lines on at least one half face of a user, wherein each of the front, mid and side facelift suture path lines has an upper segment, a lower segment, an insertion mark between the upper segment and the lower segment, and outlet marks at ends of the upper segment and the lower segment,
the one or more front facelift suture path lines being extended upwardly, rearwardly and inclinedly, starting from a position of a nasolabial fold to a malar mound and then ending at a position adjacent to an ear of at least the at least one half face of the user while the insertion mark of each of the one or more front facelift suture path lines are positioned around the malar mound, wherein the outlet mark of the lower segment of each of the one or more front facelift suture path lines is extended passing through the nasolabial fold and marked beyond the nasolabial fold,
the one or more mid facelift suture path lines being extended upwardly, rearwardly and inclinedly, starting from a position of a marionette line to a cheek and then ending at a position adjacent to a temple portion on the at least one half face of the user while the insertion mark is positioned at the cheek of the user, wherein the outlet mark of the lower segment of each of the one or more mid facelift suture path lines is extended passing through the marionette line and marked beyond the marionette line,
the one or more side facelift suture path lines being extended upwardly, starting from a jowl position to a crows feet position on the at least one half face of the user while the insertion mark is positioned below the one or more mid facelift suture path lines;
(ii) implanting invasive sutures in a tissue layer of the at least one half face of the user along and underlying the one or more front facelift suture path lines, the one or more mid facelift suture path lines and the one or more side facelift suture path lines marked on the at least one half face of the user; and
(iii) performing facial shaping by tightening the tissue layer through the invasive sutures implanted.